These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30452137)

  • 21. Addressing Unhealthy Substance Use in Primary Care.
    Pace CA; Uebelacker LA
    Med Clin North Am; 2018 Jul; 102(4):567-586. PubMed ID: 29933816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model.
    Pade PA; Cardon KE; Hoffman RM; Geppert CM
    J Subst Abuse Treat; 2012 Dec; 43(4):446-50. PubMed ID: 22980449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Educating psychologists about substance abuse.
    Miller WR
    Subst Abus; 2002 Sep; 23(3 Suppl):289-303. PubMed ID: 23581002
    [No Abstract]   [Full Text] [Related]  

  • 24. Characteristics of physicians presenting for assessment at a behavioral health center.
    McGovern MP; Angres DH; Leon S
    J Addict Dis; 2000; 19(2):59-73. PubMed ID: 10809520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Educating social workers to work with individuals affected by substance use disorders.
    Straussner SL; Senreich E
    Subst Abus; 2002 Sep; 23(3 Suppl):319-40. PubMed ID: 23581004
    [No Abstract]   [Full Text] [Related]  

  • 26. Recommendations for implementing effective substance abuse education in pharmacy practice.
    Dole EJ; Tommasello A
    Subst Abus; 2002 Sep; 23(3 Suppl):263-71. PubMed ID: 23581000
    [No Abstract]   [Full Text] [Related]  

  • 27. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population.
    McDermott KA; Griffin ML; Connery HS; Hilario EY; Fiellin DA; Fitzmaurice GM; Weiss RD
    J Clin Psychiatry; 2015 Feb; 76(2):189-94. PubMed ID: 25562462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.
    D'Onofrio G; O'Connor PG; Pantalon MV; Chawarski MC; Busch SH; Owens PH; Bernstein SL; Fiellin DA
    JAMA; 2015 Apr; 313(16):1636-44. PubMed ID: 25919527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
    Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
    Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of allied health professionals in substance abuse education.
    Bonaguro JA; Nalette E; Seibert ML
    Subst Abus; 2002 Sep; 23(3 Suppl):169-83. PubMed ID: 23580994
    [No Abstract]   [Full Text] [Related]  

  • 32. [Addicted to alcohol and drugs. "Addiction in the elderly is not a side issue" (interview by Dr. Robert Bublak)].
    Geyer D
    MMW Fortschr Med; 2012 Mar; 154(4):6-7. PubMed ID: 22619824
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
    Mammen K; Bell J
    Expert Opin Pharmacother; 2009 Oct; 10(15):2537-44. PubMed ID: 19708849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and brief intervention for alcohol problems in an underserved population: development of baseline data via patient exit interviews.
    Hogan B; Adams S; Wahid Z; Wilson S
    Subst Abus; 2005 Dec; 26(3-4):53-7. PubMed ID: 16837415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating opiate addiction, Part I. Detoxification and maintenance.
    Harv Ment Health Lett; 2004 Dec; 21(6):4-6. PubMed ID: 15717347
    [No Abstract]   [Full Text] [Related]  

  • 36. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case series of buprenorphine/naloxone treatment in a primary care practice.
    Doolittle B; Becker W
    Subst Abus; 2011 Oct; 32(4):262-5. PubMed ID: 22014257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription pain medication dependence.
    Dodrill CL; Helmer DA; Kosten TR
    Am J Psychiatry; 2011 May; 168(5):466-71. PubMed ID: 21536702
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and validation of a Client Problem Profile and Index for drug treatment.
    Joe GW; Simpson DD; Greener JM; Rowan-Szal GA
    Psychol Rep; 2004 Aug; 95(1):215-34. PubMed ID: 15460378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal drug withdrawal.
    Barthell JE; Mrozek JD
    Minn Med; 2013 Mar; 96(3):48-50. PubMed ID: 23930471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.